...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >TO IDENTIFY, EVALUATE, AND ANALYZE THE POSSIBLE DRUG-DRUG INTERACTIONS IN PATIENTS DIAGNOSED AS TYPE 2 DIABETES MELLITUS WITH HYPERTENSION IN A TERTIARY CARE TEACHING HOSPITAL
【24h】

TO IDENTIFY, EVALUATE, AND ANALYZE THE POSSIBLE DRUG-DRUG INTERACTIONS IN PATIENTS DIAGNOSED AS TYPE 2 DIABETES MELLITUS WITH HYPERTENSION IN A TERTIARY CARE TEACHING HOSPITAL

机译:鉴定,评估和分析在三级教学医院诊断为高血压的2型糖尿病患者中可能的药物-药物相互作用

获取原文
           

摘要

Objective: To identify, evaluate, and analyze the possible drug-drug interactions (DDIs) in patients diagnosed as Type 2 diabetes mellitus with hypertension in a tertiary care teaching hospital Davangere. Methods: This prospective interventional study was conducted for a period of 6 months. Data were collected from patients who were prescribed with at least one antidiabetic drug and at least one antihypertensive drug at the same time. Data were analyzed for DDIs by using software Micromedex and other resources. Results were notified to the physicians for modification or alteration in the drug therapy. Results: A total of 150 patients were analyzed out of which, 60.67% were male, and the rest 39.33% were female. In terms of interactions present, 95 (63.33%) prescriptions had one or more interactions. Antihypertensive drugs most frequently seen in prescriptions were diuretics (24.44%). Antidiabetic drugs seen frequently prescribed are biguanides (34.36%). A total of 167 possible DDIs were obtained. Angiotensin-converting enzyme inhibitors were most frequently involved antihypertensive drug in DDIs, with 60 of all possible DDIs identified. Insulin and biguanides were most frequently involved antidiabetic drugs in DDIs, with 58 each of all possible DDIs identified. Most frequently interacting drug pair was insulin + metformin (n=19). Conclusion: For every possible DDIs found in the prescription, the appropriate intervention was advised from the investigator’s part as well as provision for a physician to review and initiate modification of his choice.
机译:目的:在一家三级教学医院Davangere中,确定,评估和分析诊断为2型糖尿病合并高血压的患者可能的药物相互作用。方法:这项前瞻性干预研究进行了6个月。数据是从同时开处方至少一种抗糖尿病药和至少一种降压药的患者中收集的。使用软件Micromedex和其他资源对数据进行了DDI分析。将结果通知医师以进行药物治疗的修改或变更。结果:共分析150例患者,其中男性占60.67%,女性占39.33%。就目前存在的相互作用而言,有95种(63.33%)处方具有一种或多种相互作用。处方中最常见的降压药是利尿剂(24.44%)。经常开出的抗糖尿病药物是双胍类药物(34.36%)。总共获得了167种DDI。血管紧张素转换酶抑制剂最常与DDI中的降压药有关,在所有可能的DDI中已鉴定出60种。胰岛素和双胍类药物是DDI中最常涉及的抗糖尿病药物,已鉴定出58种可能的DDI。相互作用最频繁的药物对是胰岛素+二甲双胍(n = 19)。结论:对于处方中发现的所有可能的DDI,研究人员均建议采取适当的干预措施,并建议医师检查并开始对其选择进行修改。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号